Alcohol Abuse

Alcohol Use Disorder (formerly Alcohol Abuse and Alcohol Dependence) is a DSM-5-TR diagnosis characterized by problematic alcohol use leading to clinically significant impairment or distress, with severity ranging from mild to severe based on the number of diagnostic criteria met.

Overview

Alcohol Use Disorder (AUD; DSM-5-TR 303.x) is a problematic pattern of alcohol use leading to clinically significant impairment or distress. The DSM-5 (2013) consolidated the previous DSM-IV diagnoses of “Alcohol Abuse” and “Alcohol Dependence” into a single Alcohol Use Disorder diagnosis with severity specifiers (mild: 2-3 criteria, moderate: 4-5, severe: 6+). The DSM-5-TR (2022) maintains this framework. The term “Alcohol Abuse” persists in lay and historical clinical usage but is no longer the formal diagnostic category.

Past-year prevalence of AUD in Canadian adults is approximately 5-7%; lifetime prevalence approximately 18%. Rates are higher in men than women, though the gender gap has been narrowing. AUD typically develops in young adulthood; severity often progresses without intervention. Approximately 75% of individuals with AUD never receive specialty treatment, partly reflecting stigma, low recognition, and limited treatment access.

Alcohol is the most widely used psychoactive substance in Canada and the third-leading preventable cause of death. Alcohol-related health consequences include hepatic disease (steatosis, hepatitis, cirrhosis), cardiovascular disease, multiple cancers (mouth, throat, esophagus, liver, breast, colorectal), neurological complications (Wernicke encephalopathy, Korsakoff syndrome, peripheral neuropathy), and substantial mental-health comorbidity.

AUD is highly comorbid. Approximately 40% of individuals with AUD have a co-occurring mental-health condition — most commonly major depressive disorder, anxiety disorders, PTSD, ADHD, and personality disorders. Co-occurring substance use disorders (particularly tobacco, cannabis, opioids, stimulants) are also common.

Treatment is highly effective. Pharmacotherapy (naltrexone, acamprosate, disulfiram, off-label gabapentin and topiramate) has substantial evidence and is underused in clinical practice. Psychotherapy (CBT, Motivational Enhancement Therapy, 12-step facilitation), couples and family interventions, and peer-support communities all produce meaningful improvement. Treatment intensity is matched to severity using standardized criteria (ASAM).

Signs and symptoms

Drinking more or longer than intended — Recurrent consumption in larger amounts or over a longer period than was intended.
Unsuccessful efforts to cut down — Persistent desire or unsuccessful efforts to cut down or control alcohol use.
Time spent on alcohol-related activities — Significant time spent obtaining, using, or recovering from alcohol use.
Craving — Persistent strong desire or urge to drink alcohol.
Failure to fulfill obligations — Recurrent alcohol use resulting in failure to fulfill major role obligations at work, school, or home.
Continued use despite social problems — Continued alcohol use despite persistent social or interpersonal problems caused or exacerbated by drinking.
Activities given up — Important social, occupational, or recreational activities given up or reduced because of alcohol use.
Use in hazardous situations — Recurrent alcohol use in situations in which it is physically hazardous (driving, operating machinery).
Continued use despite physical/psychological problems — Continued alcohol use despite knowledge of having a persistent physical or psychological problem caused or exacerbated by alcohol.
Tolerance and withdrawal — Need for markedly increased amounts to achieve intoxication; or characteristic alcohol withdrawal syndrome (autonomic hyperactivity, hand tremor, insomnia, nausea, anxiety, hallucinations, seizures) on cessation.

Diagnostic context

The DSM-5-TR criteria for Alcohol Use Disorder (303.x) require a problematic pattern of alcohol use leading to clinically significant impairment or distress, as manifested by at least 2 of the following 11 criteria within a 12-month period:

Alcohol often taken in larger amounts or over a longer period than intended.
Persistent desire or unsuccessful efforts to cut down or control use.
Significant time spent obtaining, using, or recovering from alcohol.
Craving — strong desire or urge to use alcohol.
Recurrent use resulting in failure to fulfill major role obligations.
Continued use despite persistent social or interpersonal problems caused or exacerbated by alcohol.
Important social, occupational, or recreational activities given up or reduced.
Recurrent use in physically hazardous situations.
Continued use despite knowledge of physical or psychological problems caused or exacerbated by alcohol.
Tolerance — need for markedly increased amounts or markedly diminished effect with same amount.
Withdrawal — characteristic syndrome on cessation, or use of alcohol/related substance to relieve or avoid withdrawal.

Severity specifiers: mild (2-3 criteria), moderate (4-5), severe (6+). Specify if in early remission (3-12 months without meeting criteria), sustained remission (12+ months), in a controlled environment, or on maintenance therapy.

Differential diagnosis includes social or recreational drinking, alcohol-induced mood/anxiety/psychotic disorders, primary mood/anxiety/psychotic disorders with secondary alcohol use, and medical conditions presenting with similar symptoms (delirium, dementia, hypoglycemia, seizure disorder). Validated assessment instruments include the AUDIT, AUDIT-C, CAGE, MAST, and structured clinical interviews.

Causes and risk factors

AUD develops through interaction of biological, psychological, and social factors:

Genetic factors: heritability ~50-60%. Multiple common variants of small effect contribute. Family history of AUD is one of the strongest risk factors.

Neurobiological factors: alcohol modulates GABA, glutamate, dopamine, opioid, and serotonin systems. Repeated exposure produces neuroplastic changes that contribute to tolerance, withdrawal, and craving. Functional and structural brain changes are documented in chronic AUD.

Developmental factors: early onset of drinking (before age 15) substantially elevates lifetime AUD risk. Childhood adversity, family history of AUD, ADHD, conduct disorder, and early peer drinking contexts all elevate risk.

Psychological factors: co-occurring mental-health conditions are common contributors and consequences. Mood disorders, anxiety disorders, PTSD, ADHD, and personality disorders all elevate risk.

Social and environmental factors: alcohol availability, cultural acceptability, peer drinking patterns, occupational drinking norms (some industries have substantially elevated rates), trauma exposure, and chronic stress all contribute.

Sex and gender factors: men have historically been at higher risk, but the gap is narrowing. Women experience alcohol-related harms (liver disease, cancer, psychiatric complications) at lower drinking thresholds than men due to physiological differences.

Comorbidity: ~40% of AUD has comorbid mental-health condition; AUD is itself a major risk factor for new-onset depression, anxiety, and suicide. Co-occurring tobacco use disorder is extremely common (>70%); co-occurring cannabis, opioid, and stimulant use disorders are also frequent.

Typical treatments

Evidence-based treatment combines pharmacotherapy and psychotherapy, matched to severity and patient preferences:

Pharmacotherapy (Medication-Assisted Treatment):

Naltrexone — opioid antagonist; oral daily or extended-release monthly injection. Reduces heavy drinking and craving.
Acamprosate — modulates glutamate; supports abstinence maintenance. Renal-safe alternative to naltrexone for hepatic concerns.
Disulfiram — produces aversive reaction with alcohol consumption. Effective when adherence can be supported (witnessed dosing).
Off-label: topiramate, gabapentin, baclofen — emerging evidence; useful when first-line agents not tolerated.

MAT is significantly underused in clinical practice; expansion of access is a public-health priority.

Psychotherapy:

Cognitive behavioural Therapy — strong evidence base.
Motivational Enhancement Therapy / Motivational Interviewing — useful entry-point.
12-Step Facilitation Therapy — structured approach to AA engagement; comparable outcomes to CBT and MET in Project MATCH.
behavioural Couples Therapy — strong evidence for partnered patients.
Community Reinforcement Approach.
Mindfulness-Based Relapse Prevention.

Peer support: Alcoholics Anonymous, SMART Recovery, LifeRing, Refuge Recovery. Sustained engagement correlates with better outcomes.

Levels of care: outpatient, intensive outpatient, partial hospitalization, residential, medical detoxification (required for moderate-to-severe alcohol withdrawal due to risk of seizure and delirium tremens).

Medical detoxification: moderate-to-severe alcohol withdrawal carries risk of seizure, delirium tremens, and death; medically supervised detoxification with benzodiazepine taper is the standard of care.

Treatment of comorbidity: integrated dual-diagnosis treatment for co-occurring mental-health conditions produces better outcomes than sequential or parallel care.

Brief interventions: structured 5-15 minute interventions in primary care reduce drinking in non-dependent risky drinkers; recommended by USPSTF for routine implementation.

When to seek help

Professional support is indicated when:

You drink more than you intend or have tried unsuccessfully to cut down.
Drinking is producing consequences in relationships, work, finances, health, or legal status.
You experience cravings, increased tolerance, or withdrawal symptoms (tremor, sweating, anxiety, insomnia) when not drinking.
You drink to manage depression, anxiety, sleep, trauma symptoms, or other emotional states.
Co-occurring mood or anxiety symptoms have not improved with mental-health treatment alone.
You are concealing the extent of drinking from family, partners, or healthcare providers.
Liver function tests, blood pressure, or other health markers have changed in ways suggesting alcohol contribution.

Important: if you are physically dependent on alcohol (daily heavy drinking with withdrawal symptoms), do not stop abruptly without medical supervision — alcohol withdrawal can be life-threatening (seizures, delirium tremens). Contact your physician or local addictions service for medically supervised detoxification.

Free 24-hour support: 1-866-332-2322 (Alberta Health Services Addiction Helpline, 24/7), 1-866-531-2600 (ConnexOntario, 24/7), 1-866-585-0445 (Drug & Alcohol Helpline of Ontario). For mental-health crisis: 9-8-8 (Suicide Crisis Helpline) or 1-833-456-4566 (Talk Suicide Canada).

Frequently asked questions

Is "alcohol abuse" the same as alcoholism?

"Alcoholism" is an older lay term roughly corresponding to severe Alcohol Use Disorder. The DSM-5-TR uses "Alcohol Use Disorder" with mild/moderate/severe specifiers, replacing the older Abuse/Dependence distinction. The clinical concept overlaps with "alcoholism" but is more precisely defined.

How much drinking is too much?

Canadian guidelines (CCSA, 2023) note that no level of alcohol use is risk-free, and risk of harm increases progressively with each drink. AUD diagnosis depends on patterns of impaired control, consequences, and other features rather than on quantity alone. Many people with AUD do not drink daily; some daily drinkers do not have AUD.

Should I just go to AA?

AA helps many people, particularly with sustained engagement. It is not the only option — SMART Recovery, LifeRing, and other peer-support frameworks have evidence and may fit better for some. Most clinicians recommend combining peer support with professional treatment (medication and/or therapy) for moderate-to-severe AUD.

Can I just cut down rather than quit?

For mild AUD, moderation-based approaches have evidence and may be appropriate goals. For moderate-to-severe AUD, abstinence is generally associated with better long-term outcomes. Decisions are individualized; some clinicians use a "step-down" approach starting with moderation and escalating to abstinence if moderation is not sustained.

Will medication for alcohol use disorder help if I am not ready to quit?

Naltrexone in particular has evidence for reducing heavy drinking even in individuals not committed to abstinence. The Sinclair Method specifically uses naltrexone to support drinking-pattern change without requiring initial abstinence. Medication is appropriate at multiple stages of recovery.

How long does treatment take?

Acute stabilization typically requires weeks to months; sustained recovery is multi-year. Maintenance pharmacotherapy is often appropriate for 6-12 months or longer. Peer-support engagement is frequently lifelong. Many people experience one or more relapses on the path to sustained recovery.

References

American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). APA.
Reus, V. I., et al. (2018). The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. American Journal of Psychiatry, 175(1), 86–90.
Canadian Centre on Substance Use and Addiction. (2023). Canada's Guidance on Alcohol and Health.
Anton, R. F., et al. (2006). Combined pharmacotherapies and behavioural interventions for alcohol dependence: The COMBINE study. JAMA, 295(17), 2003–2017.
World Health Organization. (2018). Global Status Report on Alcohol and Health.

Find the pattern behind what's been feeling hard

A few simple questions to help surface the concerns that may fit best.

Find Your Pattern

Find a Therapist by City

Browse therapy availability by city to see local and virtual options, explore services, and connect with a clinician who can serve your area.

Alcohol Abuse therapists in Calgary Alcohol Abuse therapists in Edmonton Alcohol Abuse therapists in Toronto Alcohol Abuse therapists in Vancouver

Find a Therapist by Province

Browse therapy options by province to see which clinicians are available to work with clients in your region.

Alcohol Abuse therapists in Alberta Alcohol Abuse therapists in Ontario

Trusted by Leading Psychology & Mental Health Organizations Across Canada

ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.

Trusted By Alberta’s Leading Psychology & Mental Health Organizations

ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Alberta and Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.

Regulated and affiliated across Alberta’s leading psychology, counselling, and mental-health organizations.

Regulated and affiliated across Canada’s leading psychology, counselling, and mental-health organizations.

Authored by

ShiftGrit Clinical Editorial Team

The ShiftGrit Clinical Editorial Team combines the insight of registered psychologists, provisional psychologists, and trained writers to create accessible, evidence-informed therapy resources. All content is clinically reviewed by a Registered Psychologist.